Clinical Trial

The Effect of ACT and Tranexamic Acid on Bleeding in Cardiac Surgery

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to the dose effect of tranexamic acid and the level of ACT on bleeding in adult cardiac surgery. The main questions it aims to answer are: 1. Does higher dose of tranexamic acid reduce the amount of bleeding and blood transfusion? 2. Does lower ACT level during cardiac surgery reduce the amount of bleeding and blood transfusion? Participants will divided into four groups which have different tranexamic acid dose and ACT level during cardiac surgery to see if there is any different in the amount of bleeding and blood transfusion.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-10-30.
Status change: Not Yet Recruiting → Recruiting 2024-02-20
Trial Details
NCT Number NCT06109155
Lead Sponsor Taichung Veterans General Hospital
Conditions Surgery, Cardiac, Tranxemic Acid, Activated Clotting Time, Heparin, Cardiopulmonary Bypass
Enrollment 150 participants
Start Date 2024-02-08
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-02-21